Literature DB >> 18069755

Re-expression of methylation-induced tumor suppressor gene silencing is associated with the state of histone modification in gastric cancer cell lines.

Chun-Feng Meng1, Xin-Jiang Zhu, Guo Peng, Dong-Qiu Dai.   

Abstract

AIM: To identify the relationship between DNA hyper-methylation and histone modification at a hyperme-thylated, silenced tumor suppressor gene promoter in human gastric cancer cell lines and to elucidate whether alteration of DNA methylation could affect histone modification.
METHODS: We used chromatin immunoprecipitation (ChIP) assay to assess the status of histone acetylation and methylation in promoter regions of the p16 and mutL homolog 1 (MLH1) genes in 2 gastric cancer cell lines, SGC-7901 and MGC-803. We used methylation-specific PCR (MSP) to evaluate the effect of 5-Aza-2'-deoxycytidine (5-Aza-dC), trichostatin A (TSA) or their combination treatment on DNA methylation status. We used RT-PCR to determine whether alterations of histone modification status after 5-Aza-dC and TSA treatment are reflected in gene expression.
RESULTS: For the p16 and MLH1 genes in two cell lines, silenced loci associated with DNA hypermethylation were characterized by histone H3-K9 hypoacetylation and hypermethylation and histone H3-K4 hypomethylation. Treatment with TSA resulted in moderately increased histone H3-K9 acetylation at the silenced loci with no effect on histone H3-K9 methylation and minimal effects on gene expression. In contrast, treatment with 5-Aza-dC rapidly reduced histone H3-K9 methylation at the silenced loci and resulted in reactivation of the two genes. Combined treatment with 5-Aza-dC and TSA was synergistic in reactivating gene expression at the loci showing DNA hypermethylation. Similarly, histone H3-K4 methylation was not affected after TSA treatment, and increased moderately at the silenced loci after 5-Aza-dC treatment.
CONCLUSION: Hypermethylation of DNA in promoter CpG islands is related to transcriptional silencing of tumor suppressor genes. Histone H3-K9 methylation in different regions of the promoters studied correlates with DNA methylation status of each gene in gastric cancer cells. However, histone H3-K9 acetylation and H3-K4 methylation inversely correlate with DNA methylation status of each gene in gastric cancer cells. Alteration of DNA methylation affects histone modification.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18069755      PMCID: PMC4171225          DOI: 10.3748/wjg.v13.i46.6166

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

1.  Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly.

Authors:  J Nakayama ; J C Rice; B D Strahl; C D Allis; S I Grewal
Journal:  Science       Date:  2001-03-15       Impact factor: 47.728

2.  DNA methyltransferase Dnmt1 associates with histone deacetylase activity.

Authors:  F Fuks; W A Burgers; A Brehm; L Hughes-Davies; T Kouzarides
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

3.  Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin.

Authors:  Antoine H F M Peters; Jacqueline E Mermoud; Dónal O'Carroll; Michaela Pagani; Dieter Schweizer; Neil Brockdorff; Thomas Jenuwein
Journal:  Nat Genet       Date:  2001-12-10       Impact factor: 38.330

Review 4.  The history of cancer epigenetics.

Authors:  Andrew P Feinberg; Benjamin Tycko
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

5.  Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine.

Authors:  Carvell T Nguyen; Daniel J Weisenberger; Mihaela Velicescu; Felicidad A Gonzales; Joy C Y Lin; Gangning Liang; Peter A Jones
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

6.  Correlation between histone lysine methylation and developmental changes at the chicken beta-globin locus.

Authors:  M D Litt; M Simpson; M Gaszner; C D Allis; G Felsenfeld
Journal:  Science       Date:  2001-08-09       Impact factor: 47.728

Review 7.  The fundamental role of epigenetic events in cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Nat Rev Genet       Date:  2002-06       Impact factor: 53.242

8.  Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability.

Authors:  A S Fleisher; M Esteller; S Wang; G Tamura; H Suzuki; J Yin; T T Zou; J M Abraham; D Kong; K N Smolinski; Y Q Shi; M G Rhyu; S M Powell; S P James; K T Wilson; J G Herman; S J Meltzer
Journal:  Cancer Res       Date:  1999-03-01       Impact factor: 12.701

9.  Dependence of histone modifications and gene expression on DNA hypermethylation in cancer.

Authors:  Jill A Fahrner; Sayaka Eguchi; James G Herman; Stephen B Baylin
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

Review 10.  Epigenetics and cancer.

Authors:  Anders H Lund; Maarten van Lohuizen
Journal:  Genes Dev       Date:  2004-10-01       Impact factor: 11.361

View more
  12 in total

1.  Modulation of histone methylation and MLH1 gene silencing by hexavalent chromium.

Authors:  Hong Sun; Xue Zhou; Haobin Chen; Qin Li; Max Costa
Journal:  Toxicol Appl Pharmacol       Date:  2009-04-17       Impact factor: 4.219

2.  EPITRANS: a database that integrates epigenome and transcriptome data.

Authors:  Soo Young Cho; Jin Choul Chai; Soo Jun Park; Hyemyung Seo; Chae-Bong Sohn; Young Seek Lee
Journal:  Mol Cells       Date:  2013-11-08       Impact factor: 5.034

3.  Histone H3K9 modifications are a local chromatin event involved in ethanol-induced neuroadaptation of the NR2B gene.

Authors:  Mei Qiang; Ashley Denny; Mai Lieu; Stephanie Carreon; Ji Li
Journal:  Epigenetics       Date:  2011-09-01       Impact factor: 4.528

4.  Decreased expression of RASSF1A and up-regulation of RASSF1C is associated with esophageal squamous cell carcinoma.

Authors:  Wei Guo; Lei Cui; Cong Wang; Yanli Guo; Supeng Shen; Gang Kuang; Zhiming Dong
Journal:  Clin Exp Metastasis       Date:  2014-04-23       Impact factor: 5.150

5.  RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma.

Authors:  Wei Guo; Cong Wang; Yanli Guo; Supeng Shen; Xin Guo; Gang Kuang; Zhiming Dong
Journal:  Clin Exp Metastasis       Date:  2015-01-13       Impact factor: 5.150

Review 6.  How to stomach an epigenetic insult: the gastric cancer epigenome.

Authors:  Nisha Padmanabhan; Toshikazu Ushijima; Patrick Tan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-17       Impact factor: 46.802

7.  Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line.

Authors:  Paweena Chunharojrith; Yuki Nakayama; Xiaobing Jiang; Rachel E Kery; Jun Ma; Cristine S De La Hoz Ulloa; Xun Zhang; Yunli Zhou; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2015-08-15       Impact factor: 4.102

8.  Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.

Authors:  David Mossman; Kyu-Tae Kim; Rodney J Scott
Journal:  BMC Cancer       Date:  2010-07-12       Impact factor: 4.430

9.  Genome-wide analysis of histone H3 lysine 27 trimethylation by ChIP-chip in gastric cancer patients.

Authors:  Li Zhang; Keli Zhong; Yong Dai; Hanxin Zhou
Journal:  J Gastroenterol       Date:  2009-03-10       Impact factor: 7.527

Review 10.  Epigenetic therapeutics in autoimmune disease.

Authors:  Moshe Szyf
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.